168 related articles for article (PubMed ID: 17846394)
1. Serious adverse drug events reported to the Food and Drug Administration, 1998-2005.
Moore TJ; Cohen MR; Furberg CD
Arch Intern Med; 2007 Sep; 167(16):1752-9. PubMed ID: 17846394
[TBL] [Abstract][Full Text] [Related]
2. Unraveling cephalosporin-associated anaphylaxis: A comprehensive analysis using FDA Adverse Event Reporting System data.
Shah D; Rukasin C; Wang C; Phillips E; Stone C
J Allergy Clin Immunol Pract; 2024 May; 12(5):1359-1361. PubMed ID: 38484872
[No Abstract] [Full Text] [Related]
3. Predicting the Severity of Adverse Events on Osteoporosis Drugs Using Attribute Weighted Logistic Regression.
Ibrahim N; Foo LK; Chua SL
Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36833984
[TBL] [Abstract][Full Text] [Related]
4. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies.
Lazarou J; Pomeranz BH; Corey PN
JAMA; 1998 Apr; 279(15):1200-5. PubMed ID: 9555760
[TBL] [Abstract][Full Text] [Related]
5. Clinical and biochemical characteristics, and outcome in 33 patients with ceftriaxone-induced liver injury.
Feng CX; Ye WY; Shan QW
Eur J Clin Pharmacol; 2024 May; ():. PubMed ID: 38809311
[TBL] [Abstract][Full Text] [Related]
6. Cannabis oil extracts for chronic pain: what else can be learned from another structured prospective cohort?
Pud D; Aamar S; Schiff-Keren B; Sheinfeld R; Brill S; Robinson D; Fogelman Y; Habib G; Sharon H; Amital H; Boltyansky B; Haroutounian S; Eisenberg E
Pain Rep; 2024 Apr; 9(2):e1143. PubMed ID: 38680212
[TBL] [Abstract][Full Text] [Related]
7. Population-scale identification of differential adverse events before and during a pandemic.
Zhang X; Sumathipala M; Zitnik M
Nat Comput Sci; 2021 Oct; 1(10):666-677. PubMed ID: 38217191
[TBL] [Abstract][Full Text] [Related]
8. Indication and adverse event profiles of denosumab and zoledronic acid: based on U.S. FDA adverse event reporting system (FAERS).
Su S; Wu L; Zhou G; Peng L; Zhao H; Wang X; Li K
Front Pharmacol; 2023; 14():1225919. PubMed ID: 38027014
[No Abstract] [Full Text] [Related]
9. Patient-Reported Reasons for Antihypertensive Medication Change: A Quantitative Study Using Social Media.
Micale C; Golder S; O'Connor K; Weissenbacher D; Gross R; Hennessy S; Gonzalez-Hernandez G
Drug Saf; 2024 Jan; 47(1):81-91. PubMed ID: 37995049
[TBL] [Abstract][Full Text] [Related]
10. An integrated phytochemical,
Ramadan SA; Kamel EM; Alruhaimi RS; Bin-Ammar A; Ewais MA; Khowailed AA; Hassanein EHM; Mahmoud AM
Saudi Pharm J; 2023 Oct; 31(10):101766. PubMed ID: 37731943
[TBL] [Abstract][Full Text] [Related]
11. Reflections on the Lack of Consideration of Ethnic Ancestry to Stratify Clozapine Dosing.
de Leon J
Psychiatry Investig; 2023 Mar; 20(3):183-195. PubMed ID: 36850057
[TBL] [Abstract][Full Text] [Related]
12. Electrolyte Disorders Associated with Piperacillin/Tazobactam: A Pharmacovigilance Study Using the FAERS Database.
Seo H; Kim E
Antibiotics (Basel); 2023 Jan; 12(2):. PubMed ID: 36830151
[TBL] [Abstract][Full Text] [Related]
13. Delta-8, a Cannabis-Derived Tetrahydrocannabinol Isomer: Evaluating Case Report Data in the Food and Drug Administration Adverse Event Reporting System (FAERS) Database.
Simon TA; Simon JH; Heaning EG; Gomez-Caminero A; Marcu JP
Drug Healthc Patient Saf; 2023; 15():25-38. PubMed ID: 36742440
[TBL] [Abstract][Full Text] [Related]
14. Consequences to Patients, Clinicians, and Manufacturers When Very Serious Adverse Drug Reactions Are Identified (1997-2019): A Qualitative Analysis from the Southern Network on Adverse Reactions (SONAR).
Lubaczewski CR; Olivieri NF; Hrushesky WR; Bennett CL
Cancer Treat Res; 2022; 184():141-149. PubMed ID: 36449194
[TBL] [Abstract][Full Text] [Related]
15. Value of a web-based pediatric drug information system to prevent serious adverse drug reactions in child and adolescent psychiatry.
Fekete S; Kulpok C; Taurines R; Egberts K; Geissler J; Gerlach M; Malonga Makosi D; König J; Urschitz MS; Toni I; Neubert A; Romanos M
J Neural Transm (Vienna); 2023 Jan; 130(1):53-63. PubMed ID: 36324035
[TBL] [Abstract][Full Text] [Related]
16. Individual Pharmacotherapy Management (IPM)-IV: Optimized Usage of Approved Antimicrobials Addressing Under-Recognized Adverse Drug Reactions and Drug-Drug Interactions in Polypharmacy.
Wolf U; Baust H; Neef R; Steinke T
Antibiotics (Basel); 2022 Oct; 11(10):. PubMed ID: 36290039
[TBL] [Abstract][Full Text] [Related]
17. An international clozapine titration guideline for clozapine: An opportunity for moving forward on personalizing clozapine treatment in India and other countries.
de Leon J
Indian J Psychiatry; 2022; 64(4):331-334. PubMed ID: 36060712
[No Abstract] [Full Text] [Related]
18. Asian Best Practices for Care of Diabetes in Elderly (ABCDE).
Kalra S; Dhar M; Afsana F; Aggarwal P; Aye TT; Bantwal G; Barua M; Bhattacharya S; Das AK; Das S; Dasgupta A; Dhakal G; Dhingra A; Esfahanian F; Gadve S; Jacob J; Kapoor N; Latheef A; Mahadeb Y; Maskey R; Naseri W; Ratnasingam J; Raza A; Saboo B; Sahay R; Shah M; Shaikh S; Sharma SK; Shrestha D; Somasundaram N; Tiwaskar M; Jawdekar A
Rev Diabet Stud; 2022 Jun; 18(2):100-134. PubMed ID: 35831938
[TBL] [Abstract][Full Text] [Related]
19. The Effectiveness and Safety of Medical Cannabis for Treating Cancer Related Symptoms in Oncology Patients.
Aviram J; Lewitus GM; Vysotski Y; Amna MA; Ouryvaev A; Procaccia S; Cohen I; Leibovici A; Akria L; Goncharov D; Mativ N; Kauffman A; Shai A; Bar-Sela G; Meiri D
Front Pain Res (Lausanne); 2022; 3():861037. PubMed ID: 35669038
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
